expanding spr throughput orders of magnitude to accelerate ...carterra-bio.com › wp-content ›...
TRANSCRIPT
![Page 1: Expanding SPR Throughput Orders of Magnitude to Accelerate ...carterra-bio.com › wp-content › uploads › 2019 › 10 › Car... · • Carterra’sLSA expands the throughput](https://reader033.vdocuments.mx/reader033/viewer/2022052722/5f0c1b077e708231d433c471/html5/thumbnails/1.jpg)
Expanding SPR Throughput Orders of Magnitude to Accelerate Therapeutic Antibody Discovery
Yasmina Noubia Abdiche, PhD Chief Scientific Officer, Carterra
![Page 2: Expanding SPR Throughput Orders of Magnitude to Accelerate ...carterra-bio.com › wp-content › uploads › 2019 › 10 › Car... · • Carterra’sLSA expands the throughput](https://reader033.vdocuments.mx/reader033/viewer/2022052722/5f0c1b077e708231d433c471/html5/thumbnails/2.jpg)
2
The Therapeutic Antibody Market is Lucrative and Growing
• mAbs are bringing transformative medicines, even “cures”, to patients
• mAbs dominate the top 10 blockbuster drugs
• A diverse, innovative and robust clinical pipeline ensures market growth
• Also, mAbs provide biosimilars, companion diagnostics, and reagents
![Page 3: Expanding SPR Throughput Orders of Magnitude to Accelerate ...carterra-bio.com › wp-content › uploads › 2019 › 10 › Car... · • Carterra’sLSA expands the throughput](https://reader033.vdocuments.mx/reader033/viewer/2022052722/5f0c1b077e708231d433c471/html5/thumbnails/3.jpg)
3
Drug Discovery is Costly, Tedious, and Fraught with Failure
• Only 20% Phase I drugs
achieve market approval
• On average, US$ 1 billion
and 12 years from bench
to market
• Understanding
Mechanism of Action
(MOA) is key to clinical
success
Antibodies to watch in 2019,
Kaplon and Reichert, MABS 2018
mAbs entering clinic,
2005-2014
![Page 4: Expanding SPR Throughput Orders of Magnitude to Accelerate ...carterra-bio.com › wp-content › uploads › 2019 › 10 › Car... · • Carterra’sLSA expands the throughput](https://reader033.vdocuments.mx/reader033/viewer/2022052722/5f0c1b077e708231d433c471/html5/thumbnails/4.jpg)
4
Prominence of Immuno-Oncology: PD-1/PD-L1 Clinical Landscape
Breakdown of trials (total 2,250 in 2018) by mAb and
their combination with other targets/therapies
The clinical trial landscape for PD1/PDL1 immune checkpoint inhibitors
Tang et al, Nature Reviews Drug Discovery 2018
Distribution of trials (total 1,716) in
combo with other (250) targets/therapies
![Page 5: Expanding SPR Throughput Orders of Magnitude to Accelerate ...carterra-bio.com › wp-content › uploads › 2019 › 10 › Car... · • Carterra’sLSA expands the throughput](https://reader033.vdocuments.mx/reader033/viewer/2022052722/5f0c1b077e708231d433c471/html5/thumbnails/5.jpg)
5
Therapeutic mAbs Work via Different MOAs
Therapeutic antibodies: their mechanisms of action and the pathological findings
they induce in toxicity studies (review), Suzuki et al, J Toxicol Pathol 2015
![Page 6: Expanding SPR Throughput Orders of Magnitude to Accelerate ...carterra-bio.com › wp-content › uploads › 2019 › 10 › Car... · • Carterra’sLSA expands the throughput](https://reader033.vdocuments.mx/reader033/viewer/2022052722/5f0c1b077e708231d433c471/html5/thumbnails/6.jpg)
6
High Throughput SPR: A Disruption in Antibody Characterization
• MAbs can achieve high specificity and affinity - leveraged in drug discovery
• Binding kinetics, affinity, and epitope are crucial parameters in assessing a
mAb’s quality and fitness for a given therapeutic application, because they
inform Mechanism Of Action
• SPR is the de facto technique for measuring binding kinetics and affinity
• Carterra’s LSA expands the throughput of SPR orders of magnitude
compared with other platforms, shifting the role of SPR upstream to
screening stages where it can streamline the library-to-leads triage
• Additionally, the LSA’s 384-ligand capacity enables high throughput epitope
binning studies, transforming the binning paradigm and revealing exquisite
epitope resolution to guide lead selection and secure IP
• Minimal sample consumption and facile assay set-up
• Fast and intuitive data analysis via dedicated Kinetic and Epitope software
![Page 7: Expanding SPR Throughput Orders of Magnitude to Accelerate ...carterra-bio.com › wp-content › uploads › 2019 › 10 › Car... · • Carterra’sLSA expands the throughput](https://reader033.vdocuments.mx/reader033/viewer/2022052722/5f0c1b077e708231d433c471/html5/thumbnails/7.jpg)
7
LSA’s Core Applications
MappingEpitope BinningKinetics/Affinity
![Page 8: Expanding SPR Throughput Orders of Magnitude to Accelerate ...carterra-bio.com › wp-content › uploads › 2019 › 10 › Car... · • Carterra’sLSA expands the throughput](https://reader033.vdocuments.mx/reader033/viewer/2022052722/5f0c1b077e708231d433c471/html5/thumbnails/8.jpg)
8
The LSA Automates a Choreography between Two Microfluidic Modules
96-Channel Printhead
(96PH)
Single Flow Cell
(SFC)
• Inject 250µl over entire array
• 1-on-384 (analyte-on-ligand) mode
• Coat chips as a “lawn”
• Exceptional sample efficiency
• Functionalize discrete spots using 200µl/spot
• Create 384-ligand array using 4 serial docks of 96PH
• Recover samples (-15µl/print)
![Page 9: Expanding SPR Throughput Orders of Magnitude to Accelerate ...carterra-bio.com › wp-content › uploads › 2019 › 10 › Car... · • Carterra’sLSA expands the throughput](https://reader033.vdocuments.mx/reader033/viewer/2022052722/5f0c1b077e708231d433c471/html5/thumbnails/9.jpg)
9
LSA Integrates Flow Printing
96-Channel Printhead
(96PH)
Create 384-ligand
array via 4 serial
docks of 96PHDeck accommodates 3x 96/384 plates
![Page 10: Expanding SPR Throughput Orders of Magnitude to Accelerate ...carterra-bio.com › wp-content › uploads › 2019 › 10 › Car... · • Carterra’sLSA expands the throughput](https://reader033.vdocuments.mx/reader033/viewer/2022052722/5f0c1b077e708231d433c471/html5/thumbnails/10.jpg)
10
LSA Integrates High Throughput SPR
Inject 250µl analyte
over entire array in a
“1-on-384” analyte-
on-ligand mode
Single Flow Cell
(SFC)
Deck accommodates 2 plate positions:
sample block and 96/384 plate
![Page 11: Expanding SPR Throughput Orders of Magnitude to Accelerate ...carterra-bio.com › wp-content › uploads › 2019 › 10 › Car... · • Carterra’sLSA expands the throughput](https://reader033.vdocuments.mx/reader033/viewer/2022052722/5f0c1b077e708231d433c471/html5/thumbnails/11.jpg)
11
Flow Print a 384-Ligand Array on the LSA
Serially dock the 96PH at 4 nested locations to create a 384-ligand array
![Page 12: Expanding SPR Throughput Orders of Magnitude to Accelerate ...carterra-bio.com › wp-content › uploads › 2019 › 10 › Car... · • Carterra’sLSA expands the throughput](https://reader033.vdocuments.mx/reader033/viewer/2022052722/5f0c1b077e708231d433c471/html5/thumbnails/12.jpg)
12
Minimal Sample Consumption
Analyte flows over entire array
(1 on 96)
Analyte flows over entire array
(1 on 384)
![Page 13: Expanding SPR Throughput Orders of Magnitude to Accelerate ...carterra-bio.com › wp-content › uploads › 2019 › 10 › Car... · • Carterra’sLSA expands the throughput](https://reader033.vdocuments.mx/reader033/viewer/2022052722/5f0c1b077e708231d433c471/html5/thumbnails/13.jpg)
13
Why It’s All About The Epitope• Epitope influences a mAb’s MOA
• Epitope is innate; it can neither be predicted by in silico methods, nor
rationally shifted/optimized by engineering, so must be SELECTED
• Epitope can be used to secure IP
• Combining different MOA’s often produces superior therapeutic
outcome
• High throughput binning can reveal the epitope landscape of an
antibody library, and when merged with functional data, can identify
biologically-significant epitope clusters.
• Epitope diversity is a surrogate for functional diversity
![Page 14: Expanding SPR Throughput Orders of Magnitude to Accelerate ...carterra-bio.com › wp-content › uploads › 2019 › 10 › Car... · • Carterra’sLSA expands the throughput](https://reader033.vdocuments.mx/reader033/viewer/2022052722/5f0c1b077e708231d433c471/html5/thumbnails/14.jpg)
14
Epitope Binning on the LSA
Analytes that
sandwich pair
with ligand
Coupled mAb
(ligand)
Buffer (no
sandwiching/
blocked)
Displacement
(< buffer baseline)
Capture
antigen
Inject
mAb
analyte
• A comprehensive epitope binning
experiment scales geometrically with
the size of the mAb panel
• The LSA provides a simple way to
explore a full 384 x 384 competition
matrix on a single chip using
<10µg/mAb and <200µg antigen
• Powerful analysis software
384-ligand array
antigen + mAb
analyte captures
are cycled over the
array
![Page 15: Expanding SPR Throughput Orders of Magnitude to Accelerate ...carterra-bio.com › wp-content › uploads › 2019 › 10 › Car... · • Carterra’sLSA expands the throughput](https://reader033.vdocuments.mx/reader033/viewer/2022052722/5f0c1b077e708231d433c471/html5/thumbnails/15.jpg)
15
Using Epitope Binning to Benchmark Discovery Platforms – OmniChicken®
A
B
CD
F
p
GE
A’ Library1 (144)
Library2 (101)
Stds (20)
Total 265 mAbs
Ching et al, submitted to MABS 2019
![Page 16: Expanding SPR Throughput Orders of Magnitude to Accelerate ...carterra-bio.com › wp-content › uploads › 2019 › 10 › Car... · • Carterra’sLSA expands the throughput](https://reader033.vdocuments.mx/reader033/viewer/2022052722/5f0c1b077e708231d433c471/html5/thumbnails/16.jpg)
16
• The human immune
response can be used to
source therapeutic
mAbs to treat infectious
disease
• Isolate mAbs by B-cell
cloning of
vaccinated/infected
individuals
• Sequence diversity is
necessary but not
sufficient to produce
functional diversity
• Epitope diversity is a
surrogate for functional
diversity
• Epitope binning can
reveal the epitope
landscape
Therapeutic mAb Cocktails for Infectious Disease
![Page 17: Expanding SPR Throughput Orders of Magnitude to Accelerate ...carterra-bio.com › wp-content › uploads › 2019 › 10 › Car... · • Carterra’sLSA expands the throughput](https://reader033.vdocuments.mx/reader033/viewer/2022052722/5f0c1b077e708231d433c471/html5/thumbnails/17.jpg)
17
Therapeutic mAb Cocktails for Infectious Disease
• High throughput binning
revealed the epitope
landscape of the human
immune response
• Inform selection of a few
benchmark clones to
probe a bigger library
• Merge with
neutralization data to
understand the
functional space
Neutralization
Select 6 benchmarksB
en
ch
ma
rks
Manuscript submitted to Nature Immunology
![Page 18: Expanding SPR Throughput Orders of Magnitude to Accelerate ...carterra-bio.com › wp-content › uploads › 2019 › 10 › Car... · • Carterra’sLSA expands the throughput](https://reader033.vdocuments.mx/reader033/viewer/2022052722/5f0c1b077e708231d433c471/html5/thumbnails/18.jpg)
18
Therapeutic mAb Cocktails for Infectious Disease
• Multiple bins were functional
• Some rare bins showed exceptionally potent neutralization
• Inform the design of a broadly neutralizing cocktail
![Page 19: Expanding SPR Throughput Orders of Magnitude to Accelerate ...carterra-bio.com › wp-content › uploads › 2019 › 10 › Car... · • Carterra’sLSA expands the throughput](https://reader033.vdocuments.mx/reader033/viewer/2022052722/5f0c1b077e708231d433c471/html5/thumbnails/19.jpg)
19
Transforming the Binning Paradigm
LSA 8K HTX
2 plates / 6 days 10 to 100+ / 1 month 10 to 100+ / 1 month
5 µg >1000 µg >1000 µg
Antibodyconsumption
per mAb
384-well plates
required
LSA 8K HTX
![Page 20: Expanding SPR Throughput Orders of Magnitude to Accelerate ...carterra-bio.com › wp-content › uploads › 2019 › 10 › Car... · • Carterra’sLSA expands the throughput](https://reader033.vdocuments.mx/reader033/viewer/2022052722/5f0c1b077e708231d433c471/html5/thumbnails/20.jpg)
20
LSA Kinetics Benchmarked against Biacore 8KmAb05 mAb09mAb21
mAb2mAb22 mAb11
mAb05mAb21 mAb09
mAb2mAb22 mAb11
LSA
Bia8K
![Page 21: Expanding SPR Throughput Orders of Magnitude to Accelerate ...carterra-bio.com › wp-content › uploads › 2019 › 10 › Car... · • Carterra’sLSA expands the throughput](https://reader033.vdocuments.mx/reader033/viewer/2022052722/5f0c1b077e708231d433c471/html5/thumbnails/21.jpg)
21
1.0E+04
1.0E+05
1.0E+06
1.0E+07
1.0E+04 1.0E+05 1.0E+06 1.0E+07
1.0E-05
1.0E-04
1.0E-03
1.0E-02
1.0E-01
1.0E-05 1.0E-04 1.0E-03 1.0E-02 1.0E-01
0.01
0.1
1
10
100
1000
0.01 0.1 1 10 100 1000
ka (M-1s-1) kd (s-1) KD (nM)
LS
A
Biacore8K
LSA Kinetics Benchmarked against Biacore 8K
• Near-identical kinetic rate and affinity constants (within 2fold) across platforms
• Tested a panel of 32 kinetically-diverse mAbs
• LSA measurements are Mean ± StDev for 8-12 reps (spots) per mAb
• Biacore are single measurements
![Page 22: Expanding SPR Throughput Orders of Magnitude to Accelerate ...carterra-bio.com › wp-content › uploads › 2019 › 10 › Car... · • Carterra’sLSA expands the throughput](https://reader033.vdocuments.mx/reader033/viewer/2022052722/5f0c1b077e708231d433c471/html5/thumbnails/22.jpg)
22
LSA Kinetics: Intra-Assay (Spot-To-Spot) ReproducibilityR
esponse (
RU
)
Time (s)
• For small panels of mAbs, use the full capacity of the 384-ligand array
to explore surface capacity
• Combine measurements from optimum capacity spots and report
parameters with statistical confidence (Mean ± StDev)
mAb 23, KD = 1.5 ± 0.3 nM for N = 12
![Page 23: Expanding SPR Throughput Orders of Magnitude to Accelerate ...carterra-bio.com › wp-content › uploads › 2019 › 10 › Car... · • Carterra’sLSA expands the throughput](https://reader033.vdocuments.mx/reader033/viewer/2022052722/5f0c1b077e708231d433c471/html5/thumbnails/23.jpg)
23
Inter-Assay Reproducibility: KD values
slope = 1.01x
R² = 0.98
0.01
0.1
1
10
100
1000
0.01 0.1 1 10 100 1000
slope = 1.20x
R² = 0.999
0.01
0.1
1
10
100
0.01 0.1 1 10 100
LSA Biacore 8K
8 mAbs30 mAbs
Each measurement is Mean ± StDev
(error bars) for 8-12 reps per interactionSingle measurements
Manuscript submitted to PlosOne, Aug 2019
![Page 24: Expanding SPR Throughput Orders of Magnitude to Accelerate ...carterra-bio.com › wp-content › uploads › 2019 › 10 › Car... · • Carterra’sLSA expands the throughput](https://reader033.vdocuments.mx/reader033/viewer/2022052722/5f0c1b077e708231d433c471/html5/thumbnails/24.jpg)
24
High Throughput Binning Provides Exquisite Epitope Resolution
Color by bin Color by ligand blockade
Manuscript submitted to PlosOne, Aug 2019
![Page 25: Expanding SPR Throughput Orders of Magnitude to Accelerate ...carterra-bio.com › wp-content › uploads › 2019 › 10 › Car... · • Carterra’sLSA expands the throughput](https://reader033.vdocuments.mx/reader033/viewer/2022052722/5f0c1b077e708231d433c471/html5/thumbnails/25.jpg)
25
High Throughput Binning Provides Exquisite Epitope Resolution
yes
no
Displaced
Displaced
Coupled
mAb
Time (s)
Response (
RU
)
Sandwiching
analytes
Blocked or
displaced
analytes
Manuscript submitted to PlosOne, Aug 2019
Color by displacement Sensorgram Overlay Plot
![Page 26: Expanding SPR Throughput Orders of Magnitude to Accelerate ...carterra-bio.com › wp-content › uploads › 2019 › 10 › Car... · • Carterra’sLSA expands the throughput](https://reader033.vdocuments.mx/reader033/viewer/2022052722/5f0c1b077e708231d433c471/html5/thumbnails/26.jpg)
26
The LSA is Disrupting Antibody Analytics
• Our value proposition:
- unprecedented throughput (50x Bia8K)
- minimal sample consumption and facile assay set-up
- high quality, reliable kinetics (within 2fold of Bia8K)
- industry-leading analysis software to expedite getting to the results
• The LSA’s high throughput shifts the role of SPR upstream in
drug discovery, where it can impact the library-to-leads triage
• High throughput binning reveals the epitope landscape quickly,
enabling exquisite epitope resolution and the identification of
mAbs with unique and mechanistically-differentiated MOA’s